The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China

In conclusion, the estimated survival of CTEPH patients at 1-, 3-, 5- and 7-year was 97.1%, 93.3%, 86.9%, and 82.0% respectively. The intervention of revascularization, including PEA and BPA, were preferred than treating with targeted drug alone in the view of long-term prognosis of CTEPH.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research